Advertisement

Topics

Perspectives: Maryland’s Law To Curb Price Gouging Gives Brand-Name Drugs A Pass

09:03 EDT 9 Aug 2017 | Kaiser Health News

Read recent commentaries about drug-cost issues.

Original Article: Perspectives: Maryland’s Law To Curb Price Gouging Gives Brand-Name Drugs A Pass

NEXT ARTICLE

More From BioPortfolio on "Perspectives: Maryland’s Law To Curb Price Gouging Gives Brand-Name Drugs A Pass"

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...